CA45440-3A - 0x00000000000067D4

Healthy Males & Females

Balance

* Stipend may pay up to reflected amount.
Start Date: 
November 12, 2025 - 3:30pm
End Date: 
January 27, 2026 - 10:00am

Study Details

Study Number: CA45440
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion
Blood Draws: 18

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Tuesday 11/4/2025
Friday 11/7/2025
Monday 11/10/2025
Tuesday 11/11/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 11/4/2025
Friday 11/7/2025
Monday 11/10/2025
Tuesday 11/11/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 11/12/2025 3:30:00 PM Monday 11/17/2025 10:00:00 AM 1 Lincoln
Return Thursday 11/20/2025 9:00:00 AM Thursday 11/20/2025 10:30:00 AM 1 Lincoln
Return Wednesday 11/26/2025 9:00:00 AM Wednesday 11/26/2025 10:00:00 AM 1 Lincoln
Return Thursday 12/11/2025 9:00:00 AM Thursday 12/11/2025 10:00:00 AM 1 Lincoln
Return Thursday 1/8/2026 9:00:00 AM Thursday 1/8/2026 10:00:00 AM 1 Lincoln
Return Tuesday 1/27/2026 9:00:00 AM Tuesday 1/27/2026 10:00:00 AM 1 Lincoln